Titre : Canaux potassiques calcium-dépendants de petite conductance

Canaux potassiques calcium-dépendants de petite conductance : Questions médicales fréquentes

Termes MeSH sélectionnés :

Mendelian Randomization Analysis
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Canaux potassiques calcium-dépendants de petite conductance : Questions médicales les plus fréquentes", "headline": "Canaux potassiques calcium-dépendants de petite conductance : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Canaux potassiques calcium-dépendants de petite conductance : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-28", "dateModified": "2025-03-25", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Canaux potassiques calcium-dépendants de petite conductance" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Canaux potassiques calcium-dépendants", "url": "https://questionsmedicales.fr/mesh/D024681", "about": { "@type": "MedicalCondition", "name": "Canaux potassiques calcium-dépendants", "code": { "@type": "MedicalCode", "code": "D024681", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.585.400.750.150" } } }, "about": { "@type": "MedicalCondition", "name": "Canaux potassiques calcium-dépendants de petite conductance", "alternateName": "Small-Conductance Calcium-Activated Potassium Channels", "code": { "@type": "MedicalCode", "code": "D051640", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Adam Szewczyk", "url": "https://questionsmedicales.fr/author/Adam%20Szewczyk", "affiliation": { "@type": "Organization", "name": "Laboratory of Intracellular Ion Channels, Nencki Institute of Experimental Biology, Polish Academy of Sciences, 02-093 Warsaw, Poland." } }, { "@type": "Person", "name": "Jun Feng", "url": "https://questionsmedicales.fr/author/Jun%20Feng", "affiliation": { "@type": "Organization", "name": "Division of Cardiothoracic Surgery, Rhode Island Hospital, Alpert Medical School of Brown University, Providence, RI, USA. Electronic address: jfeng@lifespan.org." } }, { "@type": "Person", "name": "Piotr Koprowski", "url": "https://questionsmedicales.fr/author/Piotr%20Koprowski", "affiliation": { "@type": "Organization", "name": "Laboratory of Intracellular Ion Channels, Nencki Institute of Experimental Biology, Polish Academy of Sciences, 02-093 Warsaw, Poland." } }, { "@type": "Person", "name": "Mei Yang", "url": "https://questionsmedicales.fr/author/Mei%20Yang", "affiliation": { "@type": "Organization", "name": "Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China." } }, { "@type": "Person", "name": "Qingyan Zhao", "url": "https://questionsmedicales.fr/author/Qingyan%20Zhao", "affiliation": { "@type": "Organization", "name": "Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "The association between COVID-19 and cognitive performance: A Mendelian randomization analysis.", "datePublished": "2023-03-11", "url": "https://questionsmedicales.fr/article/36905350", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/alz.13017" } }, { "@type": "ScholarlyArticle", "name": "The causal effect of gut microbiota on hepatic encephalopathy: a mendelian randomization analysis.", "datePublished": "2024-08-19", "url": "https://questionsmedicales.fr/article/39160503", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12920-024-01939-y" } }, { "@type": "ScholarlyArticle", "name": "Potential drug targets for tumors identified through Mendelian randomization analysis.", "datePublished": "2024-05-18", "url": "https://questionsmedicales.fr/article/38762700", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-024-62178-w" } }, { "@type": "ScholarlyArticle", "name": "Circulating inflammatory cytokines and the risk of sepsis: a bidirectional mendelian randomization analysis.", "datePublished": "2024-08-07", "url": "https://questionsmedicales.fr/article/39112975", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12879-024-09689-z" } }, { "@type": "ScholarlyArticle", "name": "The effect of interleukin-6 signaling on severe malaria: A Mendelian randomization analysis.", "datePublished": "2023-02-16", "url": "https://questionsmedicales.fr/article/36801374", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ijid.2023.02.008" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Protéines membranaires", "item": "https://questionsmedicales.fr/mesh/D008565" }, { "@type": "ListItem", "position": 5, "name": "Protéines de transport membranaire", "item": "https://questionsmedicales.fr/mesh/D026901" }, { "@type": "ListItem", "position": 6, "name": "Canaux ioniques", "item": "https://questionsmedicales.fr/mesh/D007473" }, { "@type": "ListItem", "position": 7, "name": "Canaux potassiques", "item": "https://questionsmedicales.fr/mesh/D015221" }, { "@type": "ListItem", "position": 8, "name": "Canaux potassiques calcium-dépendants", "item": "https://questionsmedicales.fr/mesh/D024681" }, { "@type": "ListItem", "position": 9, "name": "Canaux potassiques calcium-dépendants de petite conductance", "item": "https://questionsmedicales.fr/mesh/D051640" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Canaux potassiques calcium-dépendants de petite conductance - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Canaux potassiques calcium-dépendants de petite conductance", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-16", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Canaux potassiques calcium-dépendants de petite conductance", "description": "Comment diagnostiquer une dysfonction des canaux potassiques ?\nQuels tests sont utilisés pour évaluer ces canaux ?\nLes tests génétiques sont-ils nécessaires ?\nQuels symptômes peuvent indiquer un problème ?\nPeut-on utiliser des biomarqueurs pour le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D051640?mesh_terms=Mendelian+Randomization+Analysis&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Canaux potassiques calcium-dépendants de petite conductance", "description": "Quels sont les symptômes d'une dysfonction des canaux ?\nLes symptômes varient-ils selon l'âge ?\nY a-t-il des symptômes spécifiques aux femmes ?\nLes symptômes sont-ils toujours présents ?\nComment les symptômes affectent-ils la qualité de vie ?", "url": "https://questionsmedicales.fr/mesh/D051640?mesh_terms=Mendelian+Randomization+Analysis&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Canaux potassiques calcium-dépendants de petite conductance", "description": "Peut-on prévenir les dysfonctions des canaux ?\nL'évitement de certains médicaments est-il conseillé ?\nLes examens réguliers sont-ils importants ?\nL'éducation sur la condition est-elle utile ?\nLes activités physiques peuvent-elles prévenir des problèmes ?", "url": "https://questionsmedicales.fr/mesh/D051640?mesh_terms=Mendelian+Randomization+Analysis&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Canaux potassiques calcium-dépendants de petite conductance", "description": "Quels traitements sont disponibles pour ces dysfonctions ?\nLes médicaments peuvent-ils aider à réguler les symptômes ?\nLa thérapie physique est-elle bénéfique ?\nY a-t-il des traitements expérimentaux ?\nLes changements de mode de vie peuvent-ils aider ?", "url": "https://questionsmedicales.fr/mesh/D051640?mesh_terms=Mendelian+Randomization+Analysis&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Canaux potassiques calcium-dépendants de petite conductance", "description": "Quelles complications peuvent survenir ?\nLes complications sont-elles réversibles ?\nLes complications peuvent-elles affecter la vie quotidienne ?\nY a-t-il des risques de décès associés ?\nComment gérer les complications ?", "url": "https://questionsmedicales.fr/mesh/D051640?mesh_terms=Mendelian+Randomization+Analysis&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Canaux potassiques calcium-dépendants de petite conductance", "description": "Quels sont les facteurs de risque connus ?\nL'âge influence-t-il le risque ?\nLe stress peut-il aggraver la condition ?\nLes habitudes alimentaires jouent-elles un rôle ?\nLes maladies cardiovasculaires sont-elles un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D051640?mesh_terms=Mendelian+Randomization+Analysis&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dysfonction des canaux potassiques ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests électrophysiologiques et des analyses génétiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer ces canaux ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent l'électrophysiologie et l'imagerie cellulaire pour mesurer l'activité." } }, { "@type": "Question", "name": "Les tests génétiques sont-ils nécessaires ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent identifier des mutations spécifiques affectant les canaux potassiques." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un problème ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme des crampes musculaires ou des arythmies peuvent indiquer un problème." } }, { "@type": "Question", "name": "Peut-on utiliser des biomarqueurs pour le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de biomarqueurs spécifiques pour ces canaux." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une dysfonction des canaux ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des spasmes musculaires, des palpitations et des troubles neurologiques." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier en fonction de l'âge et de la gravité de la condition." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques aux femmes ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Certaines femmes peuvent éprouver des symptômes liés aux cycles hormonaux, comme des crampes." } }, { "@type": "Question", "name": "Les symptômes sont-ils toujours présents ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Non, les symptômes peuvent être intermittents et varier en intensité." } }, { "@type": "Question", "name": "Comment les symptômes affectent-ils la qualité de vie ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent réduire la qualité de vie en limitant les activités quotidiennes et sociales." } }, { "@type": "Question", "name": "Peut-on prévenir les dysfonctions des canaux ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Certaines mesures préventives, comme un mode de vie sain, peuvent réduire les risques." } }, { "@type": "Question", "name": "L'évitement de certains médicaments est-il conseillé ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments peuvent aggraver les symptômes et doivent être évités." } }, { "@type": "Question", "name": "Les examens réguliers sont-ils importants ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des examens réguliers peuvent aider à détecter précocement des problèmes potentiels." } }, { "@type": "Question", "name": "L'éducation sur la condition est-elle utile ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'éducation des patients et des familles peut améliorer la gestion des symptômes." } }, { "@type": "Question", "name": "Les activités physiques peuvent-elles prévenir des problèmes ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut renforcer le système musculaire et nerveux." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour ces dysfonctions ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des médicaments, des thérapies physiques et des interventions chirurgicales." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider à réguler les symptômes ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments peuvent aider à stabiliser l'activité des canaux potassiques." } }, { "@type": "Question", "name": "La thérapie physique est-elle bénéfique ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut améliorer la force musculaire et la coordination chez les patients." } }, { "@type": "Question", "name": "Y a-t-il des traitements expérimentaux ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements expérimentaux, comme la thérapie génique, sont en cours d'étude." } }, { "@type": "Question", "name": "Les changements de mode de vie peuvent-ils aider ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation équilibrée et l'exercice régulier peuvent améliorer les symptômes." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des arythmies cardiaques, des troubles neurologiques et des spasmes." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles avec un traitement approprié." } }, { "@type": "Question", "name": "Les complications peuvent-elles affecter la vie quotidienne ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent limiter les activités quotidiennes et nécessiter des ajustements." } }, { "@type": "Question", "name": "Y a-t-il des risques de décès associés ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Dans des cas extrêmes, des arythmies graves peuvent entraîner des risques de décès." } }, { "@type": "Question", "name": "Comment gérer les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "La gestion des complications nécessite un suivi médical régulier et des ajustements thérapeutiques." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque connus ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, des maladies métaboliques et des médicaments." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque augmente avec l'âge en raison de la dégradation cellulaire." } }, { "@type": "Question", "name": "Le stress peut-il aggraver la condition ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut exacerber les symptômes et augmenter le risque de complications." } }, { "@type": "Question", "name": "Les habitudes alimentaires jouent-elles un rôle ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation déséquilibrée peut contribuer à des problèmes de santé associés." } }, { "@type": "Question", "name": "Les maladies cardiovasculaires sont-elles un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent augmenter le risque de dysfonction des canaux potassiques." } } ] } ] }

Sources (10000 au total)

The association between COVID-19 and cognitive performance: A Mendelian randomization analysis.

People with COVID-19 had poorer general cognitive functioning compared to people without COVID-19. The causal link between COVID-19 and cognitive impairment is still unknown.... Mendelian randomization (MR) is a statistical approach based on genome-wide association studies (GWAS) to construct instrumental variables (IVs) and can effectively bring down the confounding bias of ... There was consistent evidence that cognitive performance was causally associated with COVID-19; this suggests that people with better cognitive performance are less likely to be infected with COVID-19... Our study provided credible evidence that cognitive performance has an impact on COVID-19. Future research should focus on long-term impact of cognitive performance on COVID-19....

The causal effect of gut microbiota on hepatic encephalopathy: a mendelian randomization analysis.

There is growing evidence for a relationship between gut microbiota and hepatic encephalopathy (HE). However, the causal nature of the relationship between gut microbiota and HE has not been thoroughl... This study utilized the large-scale genome-wide association studies (GWAS) summary statistics to evaluate the causal association between gut microbiota and HE risk. Specifically, two-sample Mendelian ... The IVW method revealed that the genus Bifidobacterium (OR = 0.363, 95% CI: 0.139-0.943, P = 0.037), the family Bifidobacteriaceae (OR = 0.359, 95% CI: 0.133-0.950, P = 0.039), and the order Bifidobac... Our MR study demonstrated a potential causal association between Bifidobacterium, Bifidobacteriaceae, and Bifidobacteriales and HE. This finding may provide new therapeutic targets for patients at ris...

Circulating inflammatory cytokines and the risk of sepsis: a bidirectional mendelian randomization analysis.

Sepsis is a life-threatening condition that is characterized by multiorgan dysfunction and caused by dysregulated cytokine networks, which are closely associated with sepsis progression and outcomes. ... Data related to 35 circulating cytokines in 31,112 individuals (including 11,643 patients with sepsis) were included in genome-wide association studies (GWASs) from the UK Biobank and FinnGen consorti... A total of 35 inflammatory cytokine genes were identified in the GWASs, and 11 cytokines, including Interleukin-1 receptor antagonist (IL-1ra), macrophage inflammatory protein 1 (MIP1α), IL-16, et al.... This comprehensive MR analysis provides insights into the potential causal mechanisms that link key cytokines, particularly MIP1α, with risk of sepsis, and the findings suggest that targeting MIP1α ma...

The effect of interleukin-6 signaling on severe malaria: A Mendelian randomization analysis.

Severe malaria remains a deadly disease for many young children in low- and middle-income countries. Levels of interleukin (IL)-6 have been shown to identify cases of severe malaria and associate with... A single nucleotide polymorphism (SNP; rs2228145) in the IL-6 receptor was chosen as a genetic variant that is known to alter IL-6 signaling. We tested this, then took this forward as an instrument to... In MR analyses using rs2228145, we did not identify an effect of decreased IL-6 signaling on severe malaria (odds ratio 1.14, 95% confidence interval 0.56-2.34, P = 0.713). The estimates of the associ... These analyses do not support a causal role for IL-6 signaling in the development of severe malaria. This result suggests IL-6 may not be causal for severe outcomes in malaria, and that therapeutic ma...

Causal association of leisure sedentary behavior with arthritis: A Mendelian randomization analysis.

This study aimed at exploring the potential causal effects of leisure sedentary behavior (LSB) on common types of arthritis.... Two-sample Mendelian randomization (MR), including both univariable MR (UVMR) and multivariable MR (MVMR) analysis, was performed to explore the effects of LSB on the risk of several common types of a... UVMR results provided evidence for the causal relationship of time spent on watching TV with overall OA [odds ratio (OR) = 1.80, 95% confidence interval (CI) = 1.45-2.23], KOA (OR = 1.86, 95% CI = 1.4... This study demonstrated the genetic causal association of prolonged TV watching time with overall OA and KOA risks....

Alcohol drinking, smoking, and cutaneous melanoma risk: Mendelian randomization analysis.

To investigate the causal relationship between poor lifestyle habits, such as smoking and drinking, and cutaneous malignant melanoma.... In the present study, alcohol consumption and smoking were used as exposure factors, and single nucleotide polymorphisms closely associated with alcohol consumption and smoking were used as instrument... We found a positive and statistically significant causal effect of alcohol intake on the risk of cutaneous malignant melanoma (OR: 2.23; 95%CI: 1.11-4.47; p=0.02). The present study showed no signific... This study provides Mendelian randomization evidence supporting alcohol consumption as a risk factor for cutaneous malignant melanoma. And the causal relationship between smoking and cutaneous maligna...

The causal effects of thyroid function and lipids on cholelithiasis: A Mendelian randomization analysis.

To investigate the relationship between function of thyroid, lipids, and cholelithiasis and to identify whether lipids mediate the causal relationship between function of thyroid and cholelithiasis.... A Mendelian randomization (MR) study of two samples was performed to determine the association of thyroid function with cholelithiasis. A two-step MR was also performed to identify whether lipid metab... The IVW method revealed that FT4 levels were correlated with an elevated risk of cholelithiasis (OR: 1.149, 95% CI: 1.082-1.283,... We demonstrated that FT4, LDL-C, and apolipoprotein B had significant causal effects on cholelithiasis, with evidence that LDL-C and apolipoprotein B mediated the effects of FT4 on cholelithiasis risk...

Smoking, alcohol consumption, and 24 gastrointestinal diseases: Mendelian randomization analysis.

Whether the positive associations of smoking and alcohol consumption with gastrointestinal diseases are causal is uncertain. We conducted this Mendelian randomization (MR) to comprehensively examine a... Genetic variants associated with smoking initiation and alcohol consumption at the genome-wide significance level were selected as instrumental variables. Genetic associations with 24 gastrointestinal... Genetic predisposition to smoking initiation was associated with increased risk of 20 of 24 gastrointestinal diseases, including 7 upper gastrointestinal diseases (gastroesophageal reflux, esophageal ... This study provides MR evidence supporting causal associations of smoking with a broad range of gastrointestinal diseases, whereas alcohol consumption was associated with only a few gastrointestinal d... The Natural Science Fund for Distinguished Young Scholars of Zhejiang Province; National Natural Science Foundation of China; Key Project of Research and Development Plan of Hunan Province; the Swedis...

The relationship between lipoprotein(a) and risk of cardiovascular disease: a Mendelian randomization analysis.

Lipoprotein(a) [Lp(a)] is one of the residual risk factors for cardiovascular disease (CVD) in the setting of optimal low-density lipoprotein cholesterol (LDL-C). The association between Lp(a) and CVD... Lp(a) (n = 377,590) was a genome-wide association study (GWAS) based on European populations from Neale Lab. Large GWAS datasets for CVD, including aortic aneurysm(AA) (n = 209,366), atrial fibrillati... Our two-sample MR, which was predominately based on IVW1, revealed a causal relationship between Lp(a) and AA (OR = 1.005, 95%CI: 1.001-1.010, P = 0.009), CHD (OR = 1.003, 95%CI 1.001-1.004, P = 0.010... This MR study suggested a causal relationship between Lp(a) and CHD, AA, and ISL, but not associated with AF, HF, IS, LIS, ISS, HBP, or PE. Our work further verifies the association between Lp(a) and ...